Allogene Therapeutics, Inc. · NASDAQ:ALLO

Kenneth Griffin reported a 7.10% stake in Allogene Therapeutics, Inc. (Schedule 13G)

Event Sep 30, 2026 · Filed Nov 16, 2026

Kenneth Griffin reported a 7.10% stake in Allogene Therapeutics, Inc., 24,680,425 shares, as a passive investor on Sep 30, 2026. Filed Nov 16, 2026 (Schedule 13G).

Stake
7.10%
Shares
24,680,425
Intent
Passive
What changed
Crossed above 5%
Filed together
7 holders

The filing in full

HolderStakeShares
Citadel Securities GP LLC4.70%16,352,007
Citadel Securities LLC4.10%14,104,798
Citadel Securities Group LP4.70%16,352,007
Citadel Advisors LLC2.40%8,328,418
Citadel Advisors Holdings LP2.40%8,328,418
Citadel GP LLC2.40%8,328,418
Kenneth Griffin7.10%24,680,425

Source

Download original · View original at SEC

Related